Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 880 | 597 | 206 | 477 | 403 |
| Gross Profit | 880 | 597 | 206 | 477 | 403 |
| Operating Expenses | 13,844 | 18,775 | 15,824 | 21,576 | 12,689 |
| Operating Income | -12,964 | -18,178 | -15,618 | -21,099 | -12,286 |
| Interest Expense | 1,027 | 1,221 | 1,512 | 1,432 | 1,903 |
| Other Income | 3,339 | -8,899 | -15,722 | -7,137 | -25 |
| Pre-tax Income | -10,652 | -28,298 | -32,852 | -29,668 | -14,214 |
| Net Income Continuous | -10,652 | -28,298 | -32,852 | -29,668 | -14,214 |
| Net Income | $-10,652 | $-28,298 | $-32,852 | $-29,668 | $-14,214 |
| EPS Basic Total Ops | -0.01 | -0.05 | -0.03 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.05 | -0.03 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.03 | -0.03 | -0.01 |
| EBITDA(a) | $-12,077 | $-17,200 | $-21,207 | $-13,434 | $-11,317 |